| Literature DB >> 30845673 |
Kevin Rudolf1, Lea A L Dejonghe2, Ingo Froböse3,4, Florian Lammer5, Lisa-Marie Rückel6, Jessica Tetz7, Andrea Schaller8,9.
Abstract
The methodology of intervention studies on physical activity (PA) promotion is of great importance regarding evidence development in complex interventions. The aim of this review was to provide an overview of the methodological quality of those studies which reported statistically significant effects of interventions promoting PA. PUBMED was searched for reviews on PA promotion to identify studies reporting effective interventions with participants of working age (16⁻67 years). Selected reviews were screened and data from primary studies with effective interventions were extracted to assess methodological quality. Forty-six reviews with 600 primary studies were identified, of which 33 met the inclusion criteria. Twenty-one studies were conducted as randomized controlled trials, 13 included an intervention control group, 25 measured PA by questionnaire, and 13 included objective measurements. Information on used statistics was often scarce, and long-term follow-up measurements were frequently missing. The overall methodological quality was moderate for randomized studies and low for non-randomized studies; information on methods and results was often lacking. To overcome these methodological issues, standardized guidelines for reporting study results should be considered, not only when publishing results but also when designing studies. This review provides a solid foundation for the development of practical advice for planning application-oriented studies in PA promotion.Entities:
Keywords: assessment; evidence development; methodology; physical activity promotion; reporting guidelines; study design
Mesh:
Year: 2019 PMID: 30845673 PMCID: PMC6427597 DOI: 10.3390/ijerph16050813
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Eligibility criteria for the literature search. PA: physical activity.
| Selection Process | Inclusion Criteria | Exclusion Criteria |
|---|---|---|
| First phase (review selection) | Article type: reviews or meta-analyses | Primary outcome: not PA |
| Second phase (study selection) | Published: 2007 or later | Same as the exclusion criteria of the first search |
Figure 1Flow chart of the review selection process (step 1). Since not all included reviews provided suitable primary studies, we provide a Supplementary appendix with all reviews from which we included primary studies.
Figure 2Flow chart of the study selection process (step 2).
Methodological components of effective PA interventions.
| Study | Delphi List | Materials and Methods | Results | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Author, Year | Score [0–9] | Study Design | Group Conditions (Sample Size) | Operationalization of PA (Instrument; Time Frame) | Statistics: Sample Size Calculation (SSC) ITT Analysis (ITT) Check for Baseline Differences (CBD) Drop-Out Analysis (DOA) | Sample Size Achieved | Effect Size | Follow-Up after end of Intervention (Time; Significant Difference from Baseline) | |
| Subjective | Objective | ||||||||
| Allen et al., 2008 [ | 5 | RCT | IG ( | - | ✓ |
SSC - ITT - CBD ✓ DOA - | - | ✓ | - |
| Baker et al., 2008 [ | 6 | RCT | IG ( | ✓ | ✓ |
SSC ✓ ITT ✓ CBD ✓ DOA ✓ | ✓ | ✓ | - |
| Carr et al., 2008 [ | 5 | RCT | IG ( | - | ✓ |
SSC ✓ ITT - CBD ✓ DOA ✓ | - | ✓ | - |
| Cheung, Chow, & Parfitt, 2008 [ | 3 | RCT | IG ( | - | ✓ |
SSC - ITT - CBD ✓ DOA - | - | - | - |
| Conroy et al., 2011 [ | 4 | Randomized clinical trial: secondary analysis | IG1 ( | ✓ | - |
SSC - ITT- CBD ✓ DOA - | - | - | - |
| Dinger et al., 2007 [ | 5 | Randomized clinical trial | IG1 ( | ✓ | - |
SSC - ITT - CBD ✓ DOA - | - | ✓ | - |
| Dirige et al., 2013 [ | 4 | RCT | IG ( | ✓ | - |
SSC - ITT - CBD ✓ DOA - | - | ✓ | - |
| Dunton & Robertson, 2008 [ | 6 | RCT | IG ( | ✓ | - |
SSC ✓ ITT ✓ CBD ✓ DOA - | - | - | - |
| Ferney et al., 2009 [ | 7 | RCT | IG ( | ✓ | - |
SSC - ITT ✓ CBD ✓ DOA - | - | - | - |
| Gilson, et al., 2007 [ | 3 | RCT | IG1 ( | - | ✓ |
SSC - ITT - CBD ✓ DOA - | - | ✓ | - |
| Hemmingsson et al., 2008 [ | 3 | Randomized clinical trial | IG ( | - | ✓ |
SSC ✓ ITT - CBD - DOA - | ✓ | - | - |
| Hooker et al., 2011 [ | 2 | Quasi experimental pre-post design | IG ( | ✓ | - |
SSC - ITT - CBD - DOA - | - | - | - |
| Hurling et al., 2007 [ | 6 | RCT | IG ( | ✓ | ✓ |
SSC - ITT ✓ CBD ✓ DOA - | - | - | - |
| Katz et al., 2008 [ | 5 | Controlled educational trial | IG ( | ✓ | - |
SCC - ITT - CBD ✓ DOA - | - | - | ✓ |
| Kwak et al., 2007 [ | 1 | Cohort study | IG (approx. | - | ✓ |
SSC - ITT - CBD - DOA - | - | - | ✓ |
| Lane et al., 2010 [ | 2 | RCT | IG ( | ✓ | - |
SSC - ITT - CBD ✓ DOA ✓ | - | - | - |
| Liebreich et al., 2009 [ | 6 | RCT | IG ( | ✓ | - |
SSC - ITT ✓ CBD ✓ DOA ✓ | - | ✓ | - |
| Marcus et al., 2007 [ | 6 | RCT | IG1 ( | ✓ | - |
SSC - ITT ✓ CBD ✓ DOA - | - | - | - |
| Merom et al., 2007 [ | 7 | RCT | IG1 ( | ✓ | - |
SSC ✓ ITT ✓ CBD ✓ DOA ✓ | ✓ | - | - |
| Migneault et al., 2012 [ | 4 | RCT | IG ( | ✓ | - |
SSC ✓ ITT ✓ CBD ✓ DOA ✓ | ✓ | - | - |
| Oenema et al., 2008 [ | 6 | RCT | IG ( | ✓ | - |
SSC ✓ ITT ✓ CBD ✓ DOA ✓ | ✓ | - | - |
| Opdenacker et al., 2008 [ | 5 | RCT | IG ( | ✓ | ✓ |
SSC - ITT ✓ CBD ✓ DOA ✓ | - | - | - |
| Pekmezi et al., 2010 [ | 4 | RCT | IG1 ( | ✓ | - |
SSC - ITT - CBD - DOA - | - | - | - |
| Prestwich, Perugini, & Hurling, 2010 [ | 7 | RCT | IG1 ( | ✓ | - |
SSC ✓ ITT - CBD ✓ DOA ✓ | ✓ | ✓ | - |
| Prochaska et al., 2008 [ | 4 | RCT | IG1 ( | ✓ | - |
SSC ✓ ITT - CBD ✓ DOA - | ✓ | - | - |
| Sabti et al., 2010 [ | 2 | Cohort study | IG ( | ✓ | - |
SSC - ITT - CBD ✓ DOA - | - | - | - |
| Sherman et al., 2007 [ | 1 | Cohort study | IG ( | - | ✓ |
SSC - ITT - CBD - DOA - | - | - | - |
| Spittaels et al., 2007 [ | 6 | Randomized clinical trial | IG1 ( | ✓ | - |
SSC - ITT ✓ CBD ✓ DOA ✓ | - | - | - |
| Spittaels et al., 2007 [ | 5 | RCT | IG1 ( | ✓ | - |
SSC - ITT ✓ CBD ✓ DOA ✓ | - | - | - |
| Steele, Mummery, & Dwyer, 2007 [ | 6 | Randomized trial | IG1 ( | ✓ | - |
SSC ✓ ITT ✓ CBD ✓ DOA - | ✓ | ✓ | ✓ |
| Sternfeld et al., 2009 [ | 6 | RCT | IG ( | ✓ | - |
SSC - ITT ✓ CBD ✓ DOA - | - | - | ✓ |
| Yap et al., 2009 [ | 0 | Quasi-experimental design | IG ( | ✓ | ✓ |
SSC - ITT - CBD - DOA - | - | - | - |
| Zoellner et al., 2010 [ | 2 | Feasibility study | IG ( | - | ✓ |
SSC - ITT - CBD - DOA - | - | - | - |
✓: used/done; -: not used/not done/not reported; CBD: check for baseline-differences; CG: control group, whose participants received no intervention; DOA: drop-out analysis; ICG: control group that gets any form of intervention, including usual care and placebos; IG: intervention group; ITT: intention-to-treat analyses; PA: physical activity; RCT: randomized controlled trial; SSC: sample size calculation. a Recorded daily steps were reported in a step log. b n for at-risk subsample; total population for analysis IG n = 827, CG n = 890. c Sample size for the analysis not reported in the article; baseline values listed above.